'Lectures in Neuroscience' by Rafael Yuste, a book review by Brenda Walker
21st May 2024
We currently have an opening for a Research Scientist with a keen interest in the genetics and epigenetics of neuropsychiatric disorders.
COMPASS Pathways plc is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. Our focus is on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. We are pioneering the development of a new model of psilocybin therapy, in which our proprietary formulation of synthetic psilocybin, COMP360, is administered in conjunction with psychological support.
COMP360 has been designated a Breakthrough Therapy by the US Food and Drug Administration (FDA), for treatment-resistant depression (TRD), and we have completed a phase IIb clinical trial of psilocybin therapy for TRD, in 22 sites across Europe and North America. We are also running a phase II clinical trial of COMP360 psilocybin therapy for post-traumatic stress disorder (PTSD). COMPASS is headquartered in London, UK, with offices in New York and San Francisco in the US. Our vision is a world of mental wellbeing. www.compasspathways.com.
Preclinical research is fundamental to the COMPASS mission and one of our key investment areas. Our multi-disciplinary preclinical team brings together a range of subject matter experts with extensive academic and industrial experience to deliver innovation at the earliest stages of the drug discovery and development process.
In addition to providing the foundational science to support our investigational COMP360 psilocybin therapy on its clinical journey, we are committed to building a broad and sustainable portfolio of assets, e.g. through our Discovery Center, that will transform how mental health care is delivered. We collaborate with academics and partners at the cutting edge of science, and have a bold scientific vision to embrace translational and integrative neuroscience approaches that will move us far beyond traditional approaches to psychiatric drug discovery.
Main responsibilities include (but are not limited to):
The closing date for this job advert is unspecified. The closing date 30/04/2022 was chosen arbitrarily to support the requirements of our webpage.